1424941-91-2

Upstream product

• 22027-96-9 5-nitroveratral 
• 1424941-90-1 C₁₃H₂₆N₂O₂Si 
• 946658-23-7 2-((tert-butyldimethylsilyl)oxy)-N-ethylethan-1-amine 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 1424941-93-4 C₁₆H₁₈ClN₃O₅ 
• 1424941-94-5 C₂₄H₃₁N₃O₇S₂ 
• 1424941-88-7 C₂₂H₂₇N₃O₇S₂ 
• 1424941-95-6 C₃₆H₄₇N₃O₇ 
• 1424941-89-8 C₃₄H₄₃N₃O₇ 

Relevant academic research and scientific papers

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE

The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of Parkinson's disease may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be also used for the treatment of Huntington's disease, Alzheimer's disease, Multiple Sclerosis, Lateral Sclerosis, Neural Motor disorders.

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE

The disclosures herein provide compounds of formula 1 or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral administration, transdermal administration, transmucosal, syrups, topical, extended release, sustained release, or injection. Such compositions may be used to treatment of Parkinson's disease or neurodegenerative or metabolic conditions or its associated complications.

COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE

Provided are compounds, pharmaceutical acceptable salts, polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising the compounds may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral admimstration, syrup or injection, and may be used for the treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease multiple sclerosis lateral sclerosis and neural motor disorders.